{"description":"The trial involved standard of care systemic therapies and there could be several options of systemic therapies, adverse events data were not collected in the trial.","eventGroups":[{"deathsNumAffected":63,"deathsNumAtRisk":131,"description":"Patients receive standard palliative therapy, if needed, to address symptoms such as tumor ulceration, pain, bulky adenopathy causing arm symptoms, and other similar situations. Therapy may consist of radiotherapy alone, surgery alone, or a combination of both.\n\npalliative surgery: Undergo standard palliative surgery\n\npalliative radiation therapy: Undergo standard palliative radiotherapy","id":"EG000","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"Arm I (Continued Systemic Therapy)"},{"deathsNumAffected":58,"deathsNumAtRisk":125,"description":"Patients undergo surgery comprising breast-conserving therapy (BCT) or total mastectomy according to patient and treating physician preference. Surgery is to occur no later than 10 weeks after completion of 32 weeks of systemic therapy. Free surgical margins must be achieved with re-excision or mastectomy for patients undergoing BCT. After completion of BCT, patients undergo radiotherapy once a day, 5 days per week. Patients who had mastectomy undergo radiotherapy at the discretion of treating physician.\n\ntherapeutic conventional surgery: Undergo early surgery\n\nradiation therapy: Undergo radiotherapy","id":"EG001","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"Arm II (Early Local Therapy)"}],"frequencyThreshold":"0","timeFrame":"The trial involved standard of care systemic therapies and there could be many options of systemic therapies, adverse events data were not collected in the trial. For all-cause mortality, it was assessed every 3 months within 2 years and every 6 months between 2-5 years, up to 5 years."}